Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities
- PMID: 1673382
Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities
Abstract
Evidence is presented that human serum contains a single enzyme with both paraoxonase and arylesterase activities. Throughout the steps of purification and after obtaining over 600-fold purification of the enzyme, the arylesterase activity (measured with phenylacetate as the substrate) co-eluted and retained the same ratio of activity to paraoxonase activity as it had in the initial plasma sample. Paraoxon and DFP (diisopropylfluorophosphate) both complete with phenylacetate as substrates; the inhibition is of mixed type with paraoxon and competitive with DFP. Paraoxonase and arylesterase activities require calcium, and both are inhibited to the same degree by EDTA. Purified arylesterase/paraoxonase is a glycoprotein with a minimal molecular weight of about 43,000. It has up to three sugar chains per molecule, and carbohydrate represents about 15.8% of the total weight. The enzyme has an isoelectric point of 5.1. Its amino acid composition shows nothing unusual, except for a relatively high content of leucine. We conclude that human serum arylesterase and paraoxonase activities are catalyzed by a single enzyme, capable of hydrolyzing a broad spectrum of organophosphate substrates and a number of aromatic carboxylic acid esters. Studies on the genetically determined polymorphism responsible for two allozymic forms (A and B) of the esterase are described in the following paper.
Similar articles
-
Characteristics of the genetically determined allozymic forms of human serum paraoxonase/arylesterase.Drug Metab Dispos. 1991 Jan-Feb;19(1):107-12. Drug Metab Dispos. 1991. PMID: 1673383
-
Identification of two rat liver proteins with paraoxonase activity: biochemical evidence for the identity of paraoxonase and arylesterase.Chem Biol Interact. 1999 May 14;119-120:263-75. doi: 10.1016/s0009-2797(99)00036-8. Chem Biol Interact. 1999. PMID: 10421461
-
The polymorphic paraoxonase/arylesterase isozymes of human serum.Fed Proc. 1984 May 15;43(8):2338-41. Fed Proc. 1984. PMID: 6325253
-
The human serum paraoxonase/arylesterase polymorphism.Am J Hum Genet. 1983 Nov;35(6):1126-38. Am J Hum Genet. 1983. PMID: 6316781 Free PMC article.
-
Studies on human serum paraoxonase/arylesterase.Chem Biol Interact. 1993 Jun;87(1-3):25-34. doi: 10.1016/0009-2797(93)90022-q. Chem Biol Interact. 1993. PMID: 8393742
Cited by
-
Oxidative Stress Biomarkers and Peripheral Endothelial Dysfunction in Rheumatoid Arthritis: A Monocentric Cross-Sectional Case-Control Study.Molecules. 2020 Aug 25;25(17):3855. doi: 10.3390/molecules25173855. Molecules. 2020. PMID: 32854225 Free PMC article.
-
Grape seed extract prevents chlorpyrifos-induced toxicity in rat liver through the modulation of phase I detoxification pathway.Environ Sci Pollut Res Int. 2024 Mar;31(12):18566-18578. doi: 10.1007/s11356-024-32201-8. Epub 2024 Feb 13. Environ Sci Pollut Res Int. 2024. PMID: 38349500
-
The effects of cranberry juice on serum glucose, apoB, apoA-I, Lp(a), and Paraoxonase-1 activity in type 2 diabetic male patients.J Res Med Sci. 2012 Apr;17(4):355-60. J Res Med Sci. 2012. PMID: 23267397 Free PMC article.
-
Arylesterase Activity of Paraoxonase-1 in Serum and Cerebrospinal Fluid of Patients with Alzheimer's Disease and Vascular Dementia.Antioxidants (Basel). 2020 May 25;9(5):456. doi: 10.3390/antiox9050456. Antioxidants (Basel). 2020. PMID: 32466344 Free PMC article.
-
Characterization of human paraoxonase 1 variants suggest that His residues at 115 and 134 positions are not always needed for the lactonase/arylesterase activities of the enzyme.Protein Sci. 2013 Dec;22(12):1799-807. doi: 10.1002/pro.2380. Epub 2013 Oct 26. Protein Sci. 2013. PMID: 24123308 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases